Erratum: Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas (Journal of Clinical Investigation (2004) 114 (300-308) doi:10.1172/JCI200419855);Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas

Journal of Clinical Investigation

Volumn 114, Issue 2, 2004, Pages 300-308

  Shimizu, Koichi ^a   Shichiri, Masayoshi ^b   Libby, Peter ^a   Lee, Richard T ^a   Mitchell, Richard N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; MACROPHAGE ELASTASE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM; ANEURYSM RUPTURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; AORTA STENOSIS; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMA; CELLULAR IMMUNITY; COLLAGEN DEGRADATION; CONGENITAL DISORDER; CONTROLLED STUDY; ELASTOLYSIS; EXTRACELLULAR MATRIX; IMMUNE RESPONSE; INFLAMMATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

EID: 4043106458     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200419855C1     Document Type: Erratum

References (51)

1. Hallett, J.W., Jr. 2000. Management of abdominal aortic aneurysms. Mayo Clin. Proc. 75:395-399.
2. Glagov, S. 1977. Morphology of collagen and elastin fibers in atherosclerotic lesions. Adv. Exp. Med. Biol. 82:767-773.
3. Campa, J.S., Greenhalgh, R.M., and Powell, J.T. 1987. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis. 65:13-21.
4. Newman, K.M., et al. 1994. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connect. Tissue Res. 30:265-276.
5. Thompson, R.W., and Parks, W.C. 1996. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800:157-174.
6. Knox, J.B., Sukhova, G.K., Whittemore, A.D., and Libby, P. 1997. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 95:205-212.
7. Juvonen, J., et al. 1997. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 17:2843-2847.
8. Amento, E.P., Ehsani, N., Palmer, H., and Libby, P. 1991. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 11:1223-1230.
9. Chandier, S., Cossins, J., Lury, J., and Wells, G. 1996. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumor necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 228:421-429.
10. Schonbeck, U., Mach, F., and Libby, P. 1998. Generation of biologically active IL-1b by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1b processing. J. Immunol. 161:3340-3346.
11. Gilat, D., Cahalon, L., Hershkoviz, R., and Lider, O. 1996. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol. Today. 17:16-20.
12. Watanabe, T., Shimokama, T., Haraoka, S., and Kishikawa, H. 1995. T lymphocytes in atherosclerotic lesions. Ann. N. Y. Acad. Sci. 748:40-55.
13. Hansson, G.K., Holm, J., and Jonasson, L. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169-175.
14. Elser, B., et al. 2002. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity. 17:703-712.
15. Schonbeck, U., Sukhova, G.K., Gerdes, N., and Libby, P. 2002. Th2 predominant immune responses prevail in human abdominal aortic aneurysm. Am. J. Pathol. 161:499-506.
16. Postlethwaite, A., Holness, M.A., Katai, H., and Raghow, R. 1992. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 90:1479-1485.
17. Lacraz, S., et al. 1992. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90:382-388.
18. Shimizu, K., et al. 2001. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat. Med. 7:738-741.
19. Shapiro, S.D., Endicott, S.K., Province, M.A., Pierce, J.A., and Campbell, E.J. 1991. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. J. Clin. Invest. 87:1828-1834.
20. Thompson, R.W., et al. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest, 96:318-326.
21. Vine, N., and Powell, J.T. 1991. Metalloproteinases in degenerative aortic disease. Clin. Sci. 81:233-239.
22. McMillan, W.D., et al. 1995. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler. Thromb. Vasc. Biol. 15:1139-1144.
23. Pyo, R., et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105:1641-1649.
24. Murphy, G., Cockett, M.I., Ward, R.V., and Docherty, A.J. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277:277-279.
25. Shapiro, S.D., Kobayashi, D.K., Pentland, A.P., and Welgus, H.G. 1993. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme-and substrate-specific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 268:8170-8175.
26. Curci, J.A., Liao, S., Huffman, M.D., Shapiro, S.D., and Thompson, R.W. 1998. Expression and locallization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J. Clin. Invest. 102:1900-1910.
27. Punturieri, A., et al. 2000. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med. 192:789-799.
28. Nagase, H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378:151-160.
29. Freestone, T., et al. 1995. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15:1145-1151.
30. Libby, P., and Lee, R.T. 2000. Matrix matters. Circulation. 102:1874-1876.
31. Tilson, M.D. 1992. Aortic aneurysms and atherosclerosis. Circulation. 85:378-379.
32. Daugherty, A., Manning, M.W., and Cassis, L.A. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105:1605-1612.
33. Longo, G.M., et al. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110:625-632. doi:10.1172/JC1200215334.
34. Shireman, P.K., et al. 1997. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta. J. Vasc. Surg. 25:157-164.
35. Carmeliet, P., et al. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439-444.
36. Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., and Phan, S.H. 2003. Dual roles of IL-4 in lung injury and fibrosis. J. Immunol. 170:2083-2092.
37. Corcoran, M.L., Stetler-Stevenson, W.G., Brown, P.D., and Wahl, L.M. 1992. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267:515-519.
38. Lanone, S., et al. 2002. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110:463-474. doi:10.1172/JCI200214136.
39. Furukawa, Y., et al. 1999. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am. J. Pathol. 155:1929-1939.
40. Wang, Z., et al. 2000. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192:1587-1600.
41. Shapiro, S.D., Campbell, E.J., Kobayashi, D.K., and Welgus, H.G. 1990. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest. 86:1204-1210.
42. Xie, B., et al. 1994. Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm. Am. J. Cardiol. 74:161-165.
43. Kumar, R., Dong, Z., and Fidler, I.J. 1996. Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J. Immunol. 157:5104-5111.
44. Gupta, S., et al. 1997. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99:2752-2761.
45. Nagano, H., et al. 1997. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 100:550-557.
46. Presti, R.M., Pollock, J.L., Dal Canto, AJ., O'Guin, A.K., and Virgin, H.W., 4th. 1998. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577-588.
47. Weck, K.E., et al. 1997. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1346-1353.
48. Huang, S., et al. 1993. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1742-1745.
49. Shichiri, M., and Hirata, Y. 2001. Antiangiogenesis signals by endostatin. FASEB J. 15:1044-1053.
50. Nakajima, K., Powers, J.C., Ashe, B.M., and Zimmerman, M. 1979. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J. Biol. Chem. 254:4027-4032.
51. Shimizu, K., Schonbeck, U., Mach, F., Libby, P., and Mitchell, R.N. 2000. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J. Immunol. 165:3506-3518.